Comparison of the efficacy of first-line combinations for metastatic clear cell renal cell carcinoma: A propensity score-matched analysis of Japanese multicenter database

被引：0
|
作者：
Yanagisawa, T. [1 ]
Mori, K. [1 ]
Fukuokaya, W. [1 ]
Kawada, T. [2 ]
Katayama, S. [2 ]
Uchimoto, T. [3 ]
Tsujino, T. [3 ]
Nishimura, K. [3 ]
Adachi, T. [4 ]
Toyoda, S. [5 ]
Komura, K. [3 ]
Takahara, K. [6 ]
Hashimoto, T. [4 ]
Fujita, K. [5 ]
Azuma, H. [3 ]
Ohno, Y. [4 ]
Shiroki, R. [6 ]
Uemura, H. [5 ]
Araki, M. [2 ]
Kimura, T. [1 ]
机构：
[1] Jikei Univ, Sch Med, Dept Urol, Tokyo, Japan
[2] Okayama Univ, Grad Sch Med, Dept Urol, Okayama, Japan
[3] Osaka Med & Pharmaceut Univ, Dept Urol, Osaka, Japan
[4] Tokyo Med Univ, Dept Urol, Tokyo, Japan
[5] Kindai Univ, Fac Med, Dept Urol, Osaka, Japan
[6] Fujita Hlth Univ, Sch Med, Dept Urol, Nagoya, Aichi, Japan
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0836
引用
收藏
页码：S1856 / S1857
页数：2
相关论文
共 50 条
  • [41] First-Line Mammalian Target of Rapamycin Inhibition in Metastatic Renal Cell Carcinoma: An Analysis of Practice Patterns From the International Metastatic Renal Cell Carcinoma Database Consortium
    Harshman, Lauren C.
    Kroeger, Nils
    Rha, Sun Young
    Donskov, Frede
    Wood, Lori
    Tantravahi, Srinivas K.
    Vaishampayan, Ulka
    Rini, Brian I.
    Knox, Jennifer
    North, Scott
    Ernst, Scott
    Yuasa, Takeshi
    Srinivas, Sandy
    Pal, Sumanta
    Heng, Daniel Y.
    Choueiri, Toni K.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (05) : 335 - 340
  • [42] First-Line Immuno-Oncology Combinations for Metastatic Clear Cell Renal Cell Carcinoma (mRCC): A Systematic Review of Phase III Clinical Trials
    Hahn, Andrew W.
    Shah, Amishi Y.
    Campbell, Matthew T.
    KIDNEY CANCER, 2021, 5 (04) : 207 - 217
  • [43] Axitinib as first-line therapy in metastatic renal cell carcinoma
    Nozawa, Masahiro
    Uemura, Hirotsugu
    TRANSLATIONAL CANCER RESEARCH, 2014, 3 (06) : 555 - 557
  • [44] Tolerability of first-line therapy for metastatic renal cell carcinoma
    Porta, Camillo
    Szczylik, Cezary
    CANCER TREATMENT REVIEWS, 2009, 35 (03) : 297 - 307
  • [45] Optimising first-line treatment for metastatic renal cell carcinoma
    Liang, Fei
    LANCET, 2020, 395 (10219): : E8 - E8
  • [46] Efficacy and safety of first-line nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma: A multicenter retrospective study
    Tanaka, Toshikazu
    Hatakeyama, Shingo
    Numakura, Kazuyuki
    Kido, Koichi
    Noro, Daisuke
    Oikawa, Masaaki
    Hosogoe, Shogo
    Tokui, Noriko
    Yamamoto, Hayato
    Narita, Shintaro
    Ito, Hiroyuki
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Kawaguchi, Toshiaki
    Habuchi, Tomonori
    Ohyama, Chikara
    INTERNATIONAL JOURNAL OF UROLOGY, 2020, 27 (12) : 1095 - 1100
  • [47] Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis
    Rosiello, Giuseppe
    Palumbo, Carlotta
    Knipper, Sophie
    Pecoraro, Angela
    Luzzago, Stefano
    St-Hilaire, Pierre-Antoine
    Tian, Zhe
    Capitanio, Umberto
    Montorsi, Francesco
    Shariat, Shahrokh F.
    Saad, Fred
    Briganti, Alberto
    Karakiewicz, Pierre, I
    WORLD JOURNAL OF UROLOGY, 2021, 39 (02) : 461 - 472
  • [48] Re: First-Line Sunitinib versus Pazopanib in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
    Laguna, M. Pilar
    JOURNAL OF UROLOGY, 2017, 197 (03): : 603 - 603
  • [49] Comparison of survival outcomes in patients with metastatic papillary vs. clear-cell renal cell carcinoma: a propensity-score analysis
    Giuseppe Rosiello
    Carlotta Palumbo
    Sophie Knipper
    Angela Pecoraro
    Stefano Luzzago
    Pierre-Antoine St-Hilaire
    Zhe Tian
    Umberto Capitanio
    Francesco Montorsi
    Shahrokh F. Shariat
    Fred Saad
    Alberto Briganti
    Pierre I. Karakiewicz
    World Journal of Urology, 2021, 39 : 461 - 472
  • [50] Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma
    Ernst, Matthew S.
    Navani, Vishal
    Wells, J. Connor
    Donskov, Frede
    Basappa, Naveen
    Labaki, Chris
    Pal, Sumanta K.
    Meza, Luis
    Wood, Lori A.
    Ernst, D. Scott
    Szabados, Bernadett
    McKay, Rana R.
    Parnis, Francis
    Suarez, Cristina
    Yuasa, Takeshi
    Lalani, Aly-Khan
    Alva, Ajjai
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    EUROPEAN UROLOGY, 2023, 84 (01) : 109 - 116
12345